281 results on '"Nabbi A"'
Search Results
2. Contributors
- Author
-
Behrouzi, Reza, primary, Binda, Olivier, additional, Chen, Xiao, additional, Choudalakis, Michel, additional, Currie, Mark A., additional, Dantas, Arthur, additional, Deng, Yafang, additional, Dukatz, Michael, additional, Ehrlich, Melanie, additional, Fang, Yimeng, additional, Fazzio, Thomas G., additional, Gopalan, Sneha, additional, Jeltsch, Albert, additional, Jia, Songtao, additional, Kirlin, Alyssa C., additional, Kobor, Michael S., additional, Kong, Yi Wen, additional, Kougnassoukou-Tchara, Pata-Eting, additional, Kruswick, Alex, additional, Kunert, Stefan, additional, Lam, Fred C., additional, Lambert, Jean-Philippe, additional, Lashgari, Anahita, additional, Li, Haitao, additional, Liu, Wei, additional, Lorton, Benjamin M., additional, Lu, Chao, additional, Mangipudy, Vaibhav S., additional, Mills, Alea A., additional, Moazed, Danesh, additional, Nabbi, Arash, additional, Pedeux, Rémy, additional, Riabowol, Karl, additional, Ricordel, Charles, additional, Shechter, David, additional, Shrestha, Padmina, additional, Smerdon, Stephen J., additional, Sun, Hong, additional, Sun, Xueqin, additional, Tallen, Gesche Riabowol née, additional, Udenwobele, Daniel, additional, Yaffe, Michael B., additional, Yang, Yang, additional, Zhang, Hui, additional, and Zhao, Fan, additional
- Published
- 2024
- Full Text
- View/download PDF
3. Examining the potential and effectiveness of water indices using multispectral sentinel-2 data to detect soil moisture as an indicator of mudflow occurrence in arid regions
- Author
-
Zahraa Al-Ali, Ammar Abulibdeh, Talal Al-Awadhi, Midhun Mohan, Noura Al Nasiri, Mohammed Al-Barwani, Sara Al Nabbi, and Meshal Abdullah
- Subjects
Spectral reflectance curve ,Soil-line method ,Spectral indices ,Flood ,Shaheen cyclone ,Physical geography ,GB3-5030 ,Environmental sciences ,GE1-350 - Abstract
This study aims to evaluate the performance and effectiveness of six spectral water indices - derived from Multispectral sentinel-2 data - to detect soil moisture and inundated area in arid regions to be used as an indicator of mudflow phenomena to predict high-risk areas. Herein, the validation of the performance of spectral indices was conducted using threshold method, spectral curve performance, and soil-line method. These indirect validation techniques play a key role in saving time, effort, and cost, particularly for large-scale and inaccessible areas. It was observed that the Normalized Difference Water Index (NDWI), Modified Normalized Difference Water Index (mNDWI), and RSWIR indices have the potential to detect soil moisture and inundated areas in arid regions. According to the temporal spectral curve performance, the spectral characteristics of water and soil moisture were distinct in the Near infrared (NIR) and Short-wave Infrared (SWIR1,2) bands. However, the rate and degree differed between these bands, depending on the amount of water in the soil. Furthermore, the soil line method supported the appropriate selection of threshold values to detect soil moisture. However, the threshold values varied with location, time, season, and between indices. We concluded that considering the factors influencing the behavior of water and soil reflectivity could support decision-makers in identifying high-risk mudflow locations.
- Published
- 2024
- Full Text
- View/download PDF
4. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
- Author
-
Das, Anirban, Sudhaman, Sumedha, Morgenstern, Daniel, Coblentz, Ailish, Chung, Jiil, Stone, Simone C, Alsafwani, Noor, Liu, Zhihui Amy, Karsaneh, Ola Abu Al, Soleimani, Shirin, Ladany, Hagay, Chen, David, Zatzman, Matthew, Cabric, Vanja, Nobre, Liana, Bianchi, Vanessa, Edwards, Melissa, Sambira Nahum, Lauren C, Ercan, Ayse B, Nabbi, Arash, Constantini, Shlomi, Dvir, Rina, Yalon-Oren, Michal, Campino, Gadi Abebe, Caspi, Shani, Larouche, Valerie, Reddy, Alyssa, Osborn, Michael, Mason, Gary, Lindhorst, Scott, Bronsema, Annika, Magimairajan, Vanan, Opocher, Enrico, De Mola, Rebecca Loret, Sabel, Magnus, Frojd, Charlotta, Sumerauer, David, Samuel, David, Cole, Kristina, Chiaravalli, Stefano, Massimino, Maura, Tomboc, Patrick, Ziegler, David S, George, Ben, Van Damme, An, Hijiya, Nobuko, Gass, David, McGee, Rose B, Mordechai, Oz, Bowers, Daniel C, Laetsch, Theodore W, Lossos, Alexander, Blumenthal, Deborah T, Sarosiek, Tomasz, Yen, Lee Yi, Knipstein, Jeffrey, Bendel, Anne, Hoffman, Lindsey M, Luna-Fineman, Sandra, Zimmermann, Stefanie, Scheers, Isabelle, Nichols, Kim E, Zapotocky, Michal, Hansford, Jordan R, Maris, John M, Dirks, Peter, Taylor, Michael D, Kulkarni, Abhaya V, Shroff, Manohar, Tsang, Derek S, Villani, Anita, Xu, Wei, Aronson, Melyssa, Durno, Carol, Shlien, Adam, Malkin, David, Getz, Gad, Maruvka, Yosef E, Ohashi, Pamela S, Hawkins, Cynthia, Pugh, Trevor J, Bouffet, Eric, and Tabori, Uri
- Subjects
Rare Diseases ,Pediatric ,Cancer ,Neurosciences ,Pediatric Cancer ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Adolescent ,Adult ,B7-H1 Antigen ,Biomarkers ,Tumor ,Child ,DNA Repair ,DNA Replication ,Female ,Germ-Line Mutation ,Humans ,Immune Checkpoint Inhibitors ,Male ,Neoplasms ,Prospective Studies ,Retrospective Studies ,Survival Analysis ,Tumor Microenvironment ,Young Adult ,Medical and Health Sciences ,Immunology - Abstract
Cancers arising from germline DNA mismatch repair deficiency or polymerase proofreading deficiency (MMRD and PPD) in children harbour the highest mutational and microsatellite insertion-deletion (MS-indel) burden in humans. MMRD and PPD cancers are commonly lethal due to the inherent resistance to chemo-irradiation. Although immune checkpoint inhibitors (ICIs) have failed to benefit children in previous studies, we hypothesized that hypermutation caused by MMRD and PPD will improve outcomes following ICI treatment in these patients. Using an international consortium registry study, we report on the ICI treatment of 45 progressive or recurrent tumors from 38 patients. Durable objective responses were observed in most patients, culminating in a 3 year survival of 41.4%. High mutation burden predicted response for ultra-hypermutant cancers (>100 mutations per Mb) enriched for combined MMRD + PPD, while MS-indels predicted response in MMRD tumors with lower mutation burden (10-100 mutations per Mb). Furthermore, both mechanisms were associated with increased immune infiltration even in 'immunologically cold' tumors such as gliomas, contributing to the favorable response. Pseudo-progression (flare) was common and was associated with immune activation in the tumor microenvironment and systemically. Furthermore, patients with flare who continued ICI treatment achieved durable responses. This study demonstrates improved survival for patients with tumors not previously known to respond to ICI treatment, including central nervous system and synchronous cancers, and identifies the dual roles of mutation burden and MS-indels in predicting sustained response to immunotherapy.
- Published
- 2022
5. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
- Author
-
Arash Nabbi, Pengbo Beck, Alberto Delaidelli, Derek A. Oldridge, Sumedha Sudhaman, Kelsey Zhu, S. Y. Cindy Yang, David T. Mulder, Jeffrey P. Bruce, Joseph N. Paulson, Pichai Raman, Yuankun Zhu, Adam C. Resnick, Poul H. Sorensen, Martin Sill, Sebastian Brabetz, Sander Lambo, David Malkin, Pascal D. Johann, Marcel Kool, David T. W. Jones, Stefan M. Pfister, Natalie Jäger, and Trevor J. Pugh
- Subjects
Paediatric neuro-oncology ,Immunogenomics ,CNS tumours ,Tumour microenvironment ,Neuroblastoma ,Medicine ,Genetics ,QH426-470 - Abstract
Abstract Background Cancer immunotherapies including immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR) T-cell therapy have shown variable response rates in paediatric patients highlighting the need to establish robust biomarkers for patient selection. While the tumour microenvironment in adults has been widely studied to delineate determinants of immune response, the immune composition of paediatric solid tumours remains relatively uncharacterized calling for investigations to identify potential immune biomarkers. Methods To inform immunotherapy approaches in paediatric cancers with embryonal origin, we performed an immunogenomic analysis of RNA-seq data from 925 treatment-naïve paediatric nervous system tumours (pedNST) spanning 12 cancer types from three publicly available data sets. Results Within pedNST, we uncovered four broad immune clusters: Paediatric Inflamed (10%), Myeloid Predominant (30%), Immune Neutral (43%) and Immune Desert (17%). We validated these clusters using immunohistochemistry, methylation immune inference and segmentation analysis of tissue images. We report shared biology of these immune clusters within and across cancer types, and characterization of specific immune cell frequencies as well as T- and B-cell repertoires. We found no associations between immune infiltration levels and tumour mutational burden, although molecular cancer entities were enriched within specific immune clusters. Conclusions Given the heterogeneity of immune infiltration within pedNST, our findings suggest personalized immunogenomic profiling is needed to guide selection of immunotherapeutic strategies.
- Published
- 2023
- Full Text
- View/download PDF
6. Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
- Author
-
Nabbi, Arash, Danesh, Arnavaz, Espin-Garcia, Osvaldo, Pedersen, Stephanie, Wellum, Johanna, Fu, Lingyan Helen, Paulson, Joseph N., Geoerger, Birgit, Marshall, Lynley V., Trippett, Tanya, Rossato, Gianluca, Pugh, Trevor J., and Hutchinson, Katherine E.
- Published
- 2023
- Full Text
- View/download PDF
7. Examining the potential and effectiveness of water indices using multispectral sentinel-2 data to detect soil moisture as an indicator of mudflow occurrence in arid regions
- Author
-
Al-Ali, Zahraa, primary, Abulibdeh, Ammar, additional, Al-Awadhi, Talal, additional, Mohan, Midhun, additional, Al Nasiri, Noura, additional, Al-Barwani, Mohammed, additional, Al Nabbi, Sara, additional, and Abdullah, Meshal, additional
- Published
- 2024
- Full Text
- View/download PDF
8. The genomic landscape of pediatric renal cell carcinomas
- Author
-
Pengbo Beck, Barbara Selle, Lukas Madenach, David T.W. Jones, Christian Vokuhl, Apurva Gopisetty, Arash Nabbi, Ines B. Brecht, Martin Ebinger, Jenny Wegert, Norbert Graf, Manfred Gessler, Stefan M. Pfister, and Natalie Jäger
- Subjects
Genomics ,Cancer ,Science - Abstract
Summary: Pediatric renal cell carcinomas (RCC) differ from their adult counterparts not only in histologic subtypes but also in clinical characteristics and outcome. However, the underlying biology is still largely unclear. For this reason, we performed whole-exome and transcriptome sequencing analyses on a cohort of 25 pediatric RCC patients with various histologic subtypes, including 10 MiT family translocation (MiT) and 10 papillary RCCs. In this cohort of pediatric RCC, we find only limited genomic overlap with adult RCC, even within the same histologic subtype. Recurrent somatic mutations in genes not previously reported in RCC were detected, such as in CCDC168, PLEKHA1, VWF, and MAP3K9. Our papillary pediatric RCCs, which represent the largest cohort to date with comprehensive molecular profiling in this age group, appeared as a distinct genomic subtype differing in terms of gene mutations and gene expression patterns not only from MiT-RCC but also from their adult counterparts.
- Published
- 2022
- Full Text
- View/download PDF
9. The Jülich high brilliance neutron source project – Improving access to neutrons
- Author
-
Gutberlet, T., Rücker, U., Zakalek, P., Cronert, T., Voigt, J., Baggemann, J., Doege, P.-E., Mauerhofer, E., Böhm, S., Dabruck, J.P., Nabbi, R., Butzek, M., Klaus, M., Lange, C., and Brückel, T.
- Published
- 2019
- Full Text
- View/download PDF
10. Compact and easy to use mesitylene cold neutron moderator for CANS
- Author
-
Cronert, T., Dabruck, J.P., Klaus, M., Lange, C., Zakalek, P., Doege, P.-E., Baggemann, J., Beßler, Y., Butzek, M., Rücker, U., Gutberlet, T., Nabbi, R., and Brückel, T.
- Published
- 2018
- Full Text
- View/download PDF
11. Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
- Author
-
Jones, David T. W., Banito, Ana, Grünewald, Thomas G. P., Haber, Michelle, Jäger, Natalie, Kool, Marcel, Milde, Till, Molenaar, Jan J., Nabbi, Arash, Pugh, Trevor J., Schleiermacher, Gudrun, Smith, Malcolm A., Westermann, Frank, and Pfister, Stefan M.
- Published
- 2019
- Full Text
- View/download PDF
12. Soluble expression of IGF1 fused to DsbA in SHuffle™ T7 strain: optimization of expression and purification by Box-Behnken design
- Author
-
Emamipour, Nabbi, Vossoughi, Manouchehr, Mahboudi, Fereidoun, Golkar, Majid, and Fard-Esfahani, Pezhman
- Published
- 2019
- Full Text
- View/download PDF
13. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
- Author
-
McClurg, Urszula L., Chit, Nay C. T. H., Azizyan, Mahsa, Edwards, Joanne, Nabbi, Arash, Riabowol, Karl T., Nakjang, Sirintra, McCracken, Stuart R., and Robson, Craig N.
- Published
- 2018
- Full Text
- View/download PDF
14. Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX
- Author
-
Nabbi-Schroeter, Danje, Elmenhorst, David, Oskamp, Angela, Laskowski, Stefanie, Bauer, Andreas, and Kroll, Tina
- Published
- 2018
- Full Text
- View/download PDF
15. ING3 promotes prostate cancer growth by activating the androgen receptor
- Author
-
Arash Nabbi, Urszula L. McClurg, Subhash Thalappilly, Amal Almami, Mahsa Mobahat, Tarek A. Bismar, Olivier Binda, and Karl T. Riabowol
- Subjects
INhibitor of growth 3 ,ING3 ,Prostate cancer ,Androgen receptor ,Prognostic biomarker ,Oncogene ,Medicine - Abstract
Abstract Background The androgen receptor (AR) is a major driver of prostate cancer, and increased AR levels and co-activators of the receptor promote the development of prostate cancer. INhibitor of Growth (ING) proteins target lysine acetyltransferase or lysine deacetylase complexes to the histone H3K4Me3 mark of active transcription, to affect chromatin structure and gene expression. ING3 is a stoichiometric member of the TIP60 lysine acetyltransferase complex implicated in prostate cancer development. Methods Biopsies of 265 patients with prostate cancer were stained for ING3, pan-cytokeratin, and DNA. LNCaP and C4-2 androgen-responsive cells were used for in vitro assays including immunoprecipitation, western blotting, Luciferase reporter assay and quantitative polymerase chain reaction. Cell viability and migration assays were performed in prostate cancer cell lines using scrambled siRNA or siRNA targeting ING3. Results We find that ING3 levels and AR activity positively correlate in prostate cancer. ING3 potentiates androgen effects, increasing expression of androgen-regulated genes and androgen response element-driven reporters to promote growth and anchorage-independent growth. Conversely, ING3 knockdown inhibits prostate cancer cell growth and invasion. ING3 activates the AR by serving as a scaffold to increase interaction between TIP60 and the AR in the cytoplasm, enhancing receptor acetylation and translocation to the nucleus. Activation is independent of ING3's ability to target the TIP60 complex to H3K4Me3, identifying a previously unknown chromatin-independent cytoplasmic activity for ING3. In agreement with in vitro observations, analysis of The Cancer Genome Atlas (TCGA) data (n = 498) and a prostate cancer tissue microarray (n = 256) show that ING3 levels are higher in aggressive prostate cancers, with high levels of ING3 predicting shorter patient survival in a low AR subgroup. Including ING3 levels with currently used indicators such as the Gleason score provides more accurate prognosis in primary prostate cancer. Conclusions In contrast to the majority of previous reports suggesting tumor suppressive functions in other cancers, our observations identify a clear oncogenic role for ING3, which acts as a co-activator of AR in prostate cancer. Data from TCGA and our previous and current tissue microarrays suggest that ING3 levels correlate with AR levels and that in patients with low levels of the receptor, ING3 level could serve as a useful prognostic biomarker.
- Published
- 2017
- Full Text
- View/download PDF
16. Chapter 7 - Epigenetically decipherING the genome: A role for PHDs
- Author
-
Tallen, Gesche Riabowol née, Yang, Yang, Dantas, Arthur, Udenwobele, Daniel, Nabbi, Arash, Ricordel, Charles, Pedeux, Rémy, Riabowol, Karl, and Binda, Olivier
- Published
- 2024
- Full Text
- View/download PDF
17. Correction to: The Jülich high-brilliance neutron source project⋆
- Author
-
Rücker, U., Cronert, T., Voigt, J., Dabruck, J. P., Doege, P. -E., Ulrich, J., Nabbi, R., Beßler, Y., Butzek, M., Büscher, M., Lange, C., Klaus, M., Gutberlet, T., and Brückel, T.
- Published
- 2019
- Full Text
- View/download PDF
18. ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal
- Author
-
Nabbi, Arash, Almami, Amal, Thakur, Satbir, Suzuki, Keiko, Boland, Donna, Bismar, Tarek A., and Riabowol, Karl
- Published
- 2015
- Full Text
- View/download PDF
19. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.
- Author
-
Nabbi, Arash, Beck, Pengbo, Delaidelli, Alberto, Oldridge, Derek A., Sudhaman, Sumedha, Zhu, Kelsey, Yang, S. Y. Cindy, Mulder, David T., Bruce, Jeffrey P., Paulson, Joseph N., Raman, Pichai, Zhu, Yuankun, Resnick, Adam C., Sorensen, Poul H., Sill, Martin, Brabetz, Sebastian, Lambo, Sander, Malkin, David, Johann, Pascal D., and Kool, Marcel
- Subjects
B cells ,PROGRAMMED cell death 1 receptors ,NERVOUS system ,PEDIATRICS ,IMMUNE checkpoint inhibitors ,CHIMERIC antigen receptors ,CHILD patients - Abstract
Background: Cancer immunotherapies including immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR) T-cell therapy have shown variable response rates in paediatric patients highlighting the need to establish robust biomarkers for patient selection. While the tumour microenvironment in adults has been widely studied to delineate determinants of immune response, the immune composition of paediatric solid tumours remains relatively uncharacterized calling for investigations to identify potential immune biomarkers. Methods: To inform immunotherapy approaches in paediatric cancers with embryonal origin, we performed an immunogenomic analysis of RNA-seq data from 925 treatment-naïve paediatric nervous system tumours (pedNST) spanning 12 cancer types from three publicly available data sets. Results: Within pedNST, we uncovered four broad immune clusters: Paediatric Inflamed (10%), Myeloid Predominant (30%), Immune Neutral (43%) and Immune Desert (17%). We validated these clusters using immunohistochemistry, methylation immune inference and segmentation analysis of tissue images. We report shared biology of these immune clusters within and across cancer types, and characterization of specific immune cell frequencies as well as T- and B-cell repertoires. We found no associations between immune infiltration levels and tumour mutational burden, although molecular cancer entities were enriched within specific immune clusters. Conclusions: Given the heterogeneity of immune infiltration within pedNST, our findings suggest personalized immunogenomic profiling is needed to guide selection of immunotherapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Transcriptional immunogenomic analysis reveals distinct immunological clusters in pediatric nervous system tumours
- Author
-
Arash Nabbi, Pengbo Beck, Alberto Delaidelli, Derek A. Oldridge, Sumedha Sudhaman, Kelsey Zhu, S.Y. Cindy Yang, David T. Mulder, Jeffrey P. Bruce, Joseph N. Paulson, Pichai Raman, Yuankun Zhu, Adam C. Resnick, Poul H. Sorensen, Martin Sill, Sebastian Brabetz, Sander Lambo, David Malkin, Pascal D. Johann, Marcel Kool, David T.W. Jones, Stefan M. Pfister, Natalie Jäger, and Trevor J. Pugh
- Abstract
SummaryTo inform immunotherapy approaches in children, we performed an immunogenomic analysis of RNA-seq data from 925 treatment-naïve pediatric nervous system tumours (pedNST) spanning 12 cancer types from three public data sets. Within pedNST, we uncovered four broad immune clusters: Pediatric Inflamed (10%), Myeloid Predominant (30%), Immune Neutral (43%) and Immune Excluded (17%). We validated these clusters using immunohistochemistry, methylation immune inference, and segmentation analysis of tissue images. We report shared biology of these immune clusters within and across cancer types, and characterization of specific immune-cell frequencies as well as T- and B-cell repertoires. We found no associations between immune infiltration levels and tumour mutational burden, although molecular cancer entities were enriched within specific immune clusters. Given the heterogeneity within pedNST, our findings suggest personalized immunogenomic profiling is needed to guide selection of immunotherapeutic strategies.
- Published
- 2022
- Full Text
- View/download PDF
21. A student-driven multilevel approach for increasing energy sustainability of remote areas in the Emilia Romagna Apennines
- Author
-
Pedrazzi, Simone, primary, Ottani, Filippo, additional, Parenti, Massimiliano, additional, Parmeggiani, Davide, additional, De Luca, Aurora, additional, Silvestro, Martina Grasso, additional, Spartà, Anna, additional, Tavani, Francesco, additional, Fontana, Pietro, additional, Martini, Niccolò, additional, Martire, Mattia, additional, Bertoni, Manuel, additional, Cannas, Luisa, additional, Benacci, Martina, additional, Beltrami, Leonardo, additional, Francini, Alessandro, additional, Zanichelli, Margherita, additional, Rossi, Gaetano, additional, Villafane, Emiliano N. Guberman, additional, Nabbi, Islam H. El, additional, and Allesina, Giulio, additional
- Published
- 2022
- Full Text
- View/download PDF
22. Transcriptional immunogenomic analysis reveals distinct immunological clusters in pediatric nervous system tumours
- Author
-
Nabbi, Arash, primary, Beck, Pengbo, additional, Delaidelli, Alberto, additional, Oldridge, Derek A., additional, Sudhaman, Sumedha, additional, Zhu, Kelsey, additional, Cindy Yang, S.Y., additional, Mulder, David T., additional, Bruce, Jeffrey P., additional, Paulson, Joseph N., additional, Raman, Pichai, additional, Zhu, Yuankun, additional, Resnick, Adam C., additional, Sorensen, Poul H., additional, Sill, Martin, additional, Brabetz, Sebastian, additional, Lambo, Sander, additional, Malkin, David, additional, Johann, Pascal D., additional, Kool, Marcel, additional, Jones, David T.W., additional, Pfister, Stefan M., additional, Jäger, Natalie, additional, and Pugh, Trevor J., additional
- Published
- 2022
- Full Text
- View/download PDF
23. Irradiation of a thorium–plutonium rodlet: Experiment and benchmark calculations
- Author
-
Insulander Björk, K., Mittag, S., Nabbi, R., Rineiski, A., Schitthelm, O., and Vezzoni, B.
- Published
- 2013
- Full Text
- View/download PDF
24. The antiproliferative and anticancerogenic effects of nano-curcumin in rat colon cancer
- Author
-
Mahmood Khaniki, Saleh Azizian, Ali Mohammad Alizadeh, Hamidreza Hemmati, Nabbi Emamipour, and Mohammad Ali Mohagheghi
- Subjects
Colon cancer ,COX-2 ,curcumin ,rat ,Medicine (General) ,R5-920 - Abstract
Background: Curcumin, the active ingredient of turmeric, has the ability to inhibit the carcinogenic pathways, and thus can prevent or postpone the carcinogenic process in different animal species. Retention time of curcumin is short due to the quick excretion of the body, so, the therapeutic effects of curcumin are restricted resulting in short-term retention in the plasma. Therefore, several methods are used for increasing the efficien-cy of curcumin in plasma and tissues. The present study is designed to evaluate the effects of the anti-proliferative and anti-carcinogenic of nano-curcumin in rat colon cancer.Methods: In this study which was performed in Cancer Research Center of Tehran University of Medical Sciences in 2012. Thirty rats have divided into control, curcumin and nano-curcumin groups. All animals received azoxymethane (15 mg/kg, s.c) as a carcinogen, once a week for two consecutive weeks. Animals received curcumin 0.2% and nano-curcumin 2 weeks before azoxymethane injection up to 14 weeks after the last injection of azoxymethane in curcumin and nano-curcumin groups, respectively. At the end of experiment, the colorectal specimens from all mucosal lesions were obtained for histo-and-immunohistochemical (Ki-67 and COX-2) studies.Results: The cytological and morphological changes of the cells in nano-curcumin group were significantly lower compared to other groups (P
- Published
- 2013
25. IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors
- Author
-
Nabbi, Arash, primary, Beck, Pengbo, additional, Delaidelli, Alberto, additional, Oldridge, Derek A, additional, Sudhaman, Sumedha, additional, Zhu, Kelsey, additional, Yang, S Y Cindy, additional, Mulder, David T, additional, Bruce, Jeffrey P, additional, Paulson, Joseph N, additional, Raman, Pichai, additional, Zhu, Yuankun, additional, Silll, Martin, additional, Brabetz, Sebastian, additional, Lambo, Sander, additional, Johann, Pascal D, additional, Resnick, Adam C, additional, Sorensen, Poul H, additional, Malkin, David, additional, Kool, Marcel, additional, Jones, David T W, additional, Pfister, Stefan M, additional, Jäger, Natalie, additional, and Pugh, Trevor J, additional
- Published
- 2022
- Full Text
- View/download PDF
26. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
- Author
-
UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique, Das, Anirban, Sudhaman, Sumedha, Morgenstern, Daniel, Coblentz, Ailish, Chung, Jiil, Stone, Simone C., Alsafwani, Noor, Liu, Zhihui Amy, Karsaneh, Ola Abu Al, Soleimani, Shirin, Ladany, Hagay, Chen, David, Zatzman, Matthew, Cabric, Vanja, Nobre, Liana, Bianchi, Vanessa, Edwards, Melissa, Sambira Nahum, Lauren C, Ercan, Ayse B., Nabbi, Arash, Constantini, Shlomi, Dvir, Rina, Yalon-Oren, Michal, Campino, Gadi Abebe, Caspi, Shani, Larouche, Valerie, Reddy, Alyssa, Osborn, Michael, Mason, Gary, Lindhorst, Scott, Bronsema, Annika, Magimairajan, Vanan, Opocher, Enrico, De Mola, Rebecca Loret, Sabel, Magnus, Frojd, Charlotta, Sumerauer, David, Samuel, David, Cole, Kristina, Chiaravalli, Stefano, Massimino, Maura, Tomboc, Patrick, Ziegler, David S., George, Ben, Van Damme, An, Hijiya, Nobuko, Gass, David, McGee, Rose B., Mordechai, Oz, Bowers, Daniel C., Laetsch, Theodore W., Lossos, Alexander, Blumenthal, Deborah T., Sarosiek, Tomasz, Yen, Lee Yi, Knipstein, Jeffrey, Bendel, Anne, Hoffman, Lindsey M., Luna-Fineman, Sandra, Zimmermann, Stefanie, Scheers, Isabelle, Nichols, Kim E., Zapotocky, Michal, Hansford, Jordan R., Maris, John M., Dirks, Peter, Taylor, Michael D., Kulkarni, Abhaya V., Shroff, Manohar, Tsang, Derek S., Villani, Anita, Xu, Wei, Aronson, Melyssa, Durno, Carol, Shlien, Adam, Malkin, David, Getz, Gad, Maruvka, Yosef E., Ohashi, Pamela S., Hawkins, Cynthia, Pugh, Trevor J., Bouffet, Eric, Tabori, Uri, UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique, Das, Anirban, Sudhaman, Sumedha, Morgenstern, Daniel, Coblentz, Ailish, Chung, Jiil, Stone, Simone C., Alsafwani, Noor, Liu, Zhihui Amy, Karsaneh, Ola Abu Al, Soleimani, Shirin, Ladany, Hagay, Chen, David, Zatzman, Matthew, Cabric, Vanja, Nobre, Liana, Bianchi, Vanessa, Edwards, Melissa, Sambira Nahum, Lauren C, Ercan, Ayse B., Nabbi, Arash, Constantini, Shlomi, Dvir, Rina, Yalon-Oren, Michal, Campino, Gadi Abebe, Caspi, Shani, Larouche, Valerie, Reddy, Alyssa, Osborn, Michael, Mason, Gary, Lindhorst, Scott, Bronsema, Annika, Magimairajan, Vanan, Opocher, Enrico, De Mola, Rebecca Loret, Sabel, Magnus, Frojd, Charlotta, Sumerauer, David, Samuel, David, Cole, Kristina, Chiaravalli, Stefano, Massimino, Maura, Tomboc, Patrick, Ziegler, David S., George, Ben, Van Damme, An, Hijiya, Nobuko, Gass, David, McGee, Rose B., Mordechai, Oz, Bowers, Daniel C., Laetsch, Theodore W., Lossos, Alexander, Blumenthal, Deborah T., Sarosiek, Tomasz, Yen, Lee Yi, Knipstein, Jeffrey, Bendel, Anne, Hoffman, Lindsey M., Luna-Fineman, Sandra, Zimmermann, Stefanie, Scheers, Isabelle, Nichols, Kim E., Zapotocky, Michal, Hansford, Jordan R., Maris, John M., Dirks, Peter, Taylor, Michael D., Kulkarni, Abhaya V., Shroff, Manohar, Tsang, Derek S., Villani, Anita, Xu, Wei, Aronson, Melyssa, Durno, Carol, Shlien, Adam, Malkin, David, Getz, Gad, Maruvka, Yosef E., Ohashi, Pamela S., Hawkins, Cynthia, Pugh, Trevor J., Bouffet, Eric, and Tabori, Uri
- Abstract
Cancers arising from germline DNA mismatch repair deficiency or polymerase proofreading deficiency (MMRD and PPD) in children harbour the highest mutational and microsatellite insertion-deletion (MS-indel) burden in humans. MMRD and PPD cancers are commonly lethal due to the inherent resistance to chemo-irradiation. Although immune checkpoint inhibitors (ICIs) have failed to benefit children in previous studies, we hypothesized that hypermutation caused by MMRD and PPD will improve outcomes following ICI treatment in these patients. Using an international consortium registry study, we report on the ICI treatment of 45 progressive or recurrent tumors from 38 patients. Durable objective responses were observed in most patients, culminating in a 3 year survival of 41.4%. High mutation burden predicted response for ultra-hypermutant cancers (>100 mutations per Mb) enriched for combined MMRD + PPD, while MS-indels predicted response in MMRD tumors with lower mutation burden (10-100 mutations per Mb). Furthermore, both mechanisms were associated with increased immune infiltration even in 'immunologically cold' tumors such as gliomas, contributing to the favorable response. Pseudo-progression (flare) was common and was associated with immune activation in the tumor microenvironment and systemically. Furthermore, patients with flare who continued ICI treatment achieved durable responses. This study demonstrates improved survival for patients with tumors not previously known to respond to ICI treatment, including central nervous system and synchronous cancers, and identifies the dual roles of mutation burden and MS-indels in predicting sustained response to immunotherapy.
- Published
- 2022
27. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
- Author
-
Das, A, Sudhaman, S, Morgenstern, D, Coblentz, A, Chung, J, Stone, SC, Alsafwani, N, Liu, ZA, Abu Al Karsaneh, O, Soleimani, S, Ladany, H, Chen, D, Zatzman, M, Cabric, V, Nobre, L, Bianchi, V, Edwards, M, Nahum, LCS, Ercan, AB, Nabbi, A, Constantini, S, Dvir, R, Yalon-Oren, M, Campino, GA, Caspi, S, Larouche, V, Reddy, A, Osborn, M, Mason, G, Lindhorst, S, Bronsema, A, Magimairajan, V, Opocher, E, De Mola, RL, Sabel, M, Frojd, C, Sumerauer, D, Samuel, D, Cole, K, Chiaravalli, S, Massimino, M, Tomboc, P, Ziegler, DS, George, B, Van Damme, A, Hijiya, N, Gass, D, McGee, RB, Mordechai, O, Bowers, DC, Laetsch, TW, Lossos, A, Blumenthal, DT, Sarosiek, T, Yen, LY, Knipstein, J, Bendel, A, Hoffman, LM, Luna-Fineman, S, Zimmermann, S, Scheers, I, Nichols, KE, Zapotocky, M, Hansford, JR, Maris, JM, Dirks, P, Taylor, MD, Kulkarni, A, Shroff, M, Tsang, DS, Villani, A, Xu, W, Aronson, M, Durno, C, Shlien, A, Malkin, D, Getz, G, Maruvka, YE, Ohashi, PS, Hawkins, C, Pugh, TJ, Bouffet, E, Tabori, U, Das, A, Sudhaman, S, Morgenstern, D, Coblentz, A, Chung, J, Stone, SC, Alsafwani, N, Liu, ZA, Abu Al Karsaneh, O, Soleimani, S, Ladany, H, Chen, D, Zatzman, M, Cabric, V, Nobre, L, Bianchi, V, Edwards, M, Nahum, LCS, Ercan, AB, Nabbi, A, Constantini, S, Dvir, R, Yalon-Oren, M, Campino, GA, Caspi, S, Larouche, V, Reddy, A, Osborn, M, Mason, G, Lindhorst, S, Bronsema, A, Magimairajan, V, Opocher, E, De Mola, RL, Sabel, M, Frojd, C, Sumerauer, D, Samuel, D, Cole, K, Chiaravalli, S, Massimino, M, Tomboc, P, Ziegler, DS, George, B, Van Damme, A, Hijiya, N, Gass, D, McGee, RB, Mordechai, O, Bowers, DC, Laetsch, TW, Lossos, A, Blumenthal, DT, Sarosiek, T, Yen, LY, Knipstein, J, Bendel, A, Hoffman, LM, Luna-Fineman, S, Zimmermann, S, Scheers, I, Nichols, KE, Zapotocky, M, Hansford, JR, Maris, JM, Dirks, P, Taylor, MD, Kulkarni, A, Shroff, M, Tsang, DS, Villani, A, Xu, W, Aronson, M, Durno, C, Shlien, A, Malkin, D, Getz, G, Maruvka, YE, Ohashi, PS, Hawkins, C, Pugh, TJ, Bouffet, E, and Tabori, U
- Abstract
Cancers arising from germline DNA mismatch repair deficiency or polymerase proofreading deficiency (MMRD and PPD) in children harbour the highest mutational and microsatellite insertion-deletion (MS-indel) burden in humans. MMRD and PPD cancers are commonly lethal due to the inherent resistance to chemo-irradiation. Although immune checkpoint inhibitors (ICIs) have failed to benefit children in previous studies, we hypothesized that hypermutation caused by MMRD and PPD will improve outcomes following ICI treatment in these patients. Using an international consortium registry study, we report on the ICI treatment of 45 progressive or recurrent tumors from 38 patients. Durable objective responses were observed in most patients, culminating in a 3 year survival of 41.4%. High mutation burden predicted response for ultra-hypermutant cancers (>100 mutations per Mb) enriched for combined MMRD + PPD, while MS-indels predicted response in MMRD tumors with lower mutation burden (10-100 mutations per Mb). Furthermore, both mechanisms were associated with increased immune infiltration even in 'immunologically cold' tumors such as gliomas, contributing to the favorable response. Pseudo-progression (flare) was common and was associated with immune activation in the tumor microenvironment and systemically. Furthermore, patients with flare who continued ICI treatment achieved durable responses. This study demonstrates improved survival for patients with tumors not previously known to respond to ICI treatment, including central nervous system and synchronous cancers, and identifies the dual roles of mutation burden and MS-indels in predicting sustained response to immunotherapy.
- Published
- 2022
28. The genomic landscape of pediatric renal cell carcinomas
- Author
-
Beck, Pengbo, primary, Selle, Barbara, additional, Madenach, Lukas, additional, Jones, David T.W., additional, Vokuhl, Christian, additional, Gopisetty, Apurva, additional, Nabbi, Arash, additional, Brecht, Ines B., additional, Ebinger, Martin, additional, Wegert, Jenny, additional, Graf, Norbert, additional, Gessler, Manfred, additional, Pfister, Stefan M., additional, and Jäger, Natalie, additional
- Published
- 2022
- Full Text
- View/download PDF
29. Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study
- Author
-
Hasan Jalili, Hossein Aminianfar, Reza Aalizadeh, Nabbi Emamipour, Ebrahim Azimi, Vahid Siavashi, Asghar Abdoli, Marzieh Eghtedardoost, Hamidreza Jamshidi, Mohammad Taqavian, Ali Teimoori, Zahra Kianmehr, and Mohammadreza Hosseinpour
- Subjects
COVID-19 Vaccines ,viruses ,Guinea Pigs ,Biology ,Antibodies, Viral ,Virus ,SARS‐CoV‐2 ,Biosafety ,Mice ,Immune system ,COVID‐19 ,Virology ,Chlorocebus aethiops ,Potency ,Animals ,Alum adjuvant ,Vaccine Potency ,Vero Cells ,SARS-CoV-2 ,Immunogenicity ,immunisation ,COVID-19 ,inactivated vaccine ,BIV1‐CovIran ,Antibodies, Neutralizing ,Macaca mulatta ,Infectious Diseases ,Editorial ,Vaccines, Inactivated ,Inactivated vaccine ,Vero cell ,Rabbits - Abstract
Summary The development of effective and safe COVID‐19 vaccines is a major move forward in our global effort to control the SARS‐CoV‐2 pandemic. The aims of this study were (1) to develop an inactivated whole‐virus SARS‐CoV‐2 candidate vaccine named BIV1‐CovIran and (2) to determine the safety and potency of BIV1‐CovIran inactivated vaccine candidate against SARS‐CoV‐2. Infectious virus was isolated from nasopharyngeal swab specimen and propagated in Vero cells with clear cytopathic effects in a biosafety level‐3 facility using the World Health Organization’s laboratory biosafety guidance related to COVID‐19. After characterisation of viral seed stocks, the virus working seed was scaled‐up in Vero cells. After chemical inactivation and purification, it was formulated with alum adjuvant. Finally, different animal species were used to determine the toxicity and immunogenicity of the vaccine candidate. The study showed the safety profile in studied animals including guinea pig, rabbit, mice and monkeys. Immunisation at two different doses (3 or 5 μg per dose) elicited a high level of SARS‐CoV‐2 specific and neutralising antibodies in mice, rabbits and nonhuman primates. Rhesus macaques were immunised with the two‐dose schedule of 5 or 3 μg of the BIV1‐CovIran vaccine and showed highly efficient protection against 104 TCID50 of SARS‐CoV‐2 intratracheal challenge compared with the control group. These results highlight the BIV1‐CovIran vaccine as a potential candidate to induce a strong and potent immune response that may be a promising and feasible vaccine to protect against SARS‐CoV‐2 infection.
- Published
- 2021
30. A student-driven multilevel approach for increasing energy sustainability of remote areas in the Emilia Romagna Apennines
- Author
-
Simone Pedrazzi, Filippo Ottani, Massimiliano Parenti, Davide Parmeggiani, Aurora De Luca, Martina Grasso Silvestro, Anna Spartà, Francesco Tavani, Pietro Fontana, Niccolò Martini, Mattia Martire, Manuel Bertoni, Luisa Cannas, Martina Benacci, Leonardo Beltrami, Alessandro Francini, Margherita Zanichelli, Gaetano Rossi, Emiliano N. Guberman Villafane, Islam H. El Nabbi, and Giulio Allesina
- Subjects
General Medicine ,General Chemistry - Abstract
This paper is aimed at discussing a series of energy sustainability solutions proposed by a master class of students in environmental engineering using analytical and visual collaborative tools. The activities described are part of the class “Sustainability and renewable sources” at the University of Modena and Reggio Emilia. Six groups of 3-4 students worked on six energy efficiency and sustainability projects chosen from a remote area of the Apennines in Emilia Romagna. The specificity of the case-study framework allowed the implementation of projects where different sustainability aspects are integrated using tools of transitional thinking: agro-food production, use of renewable energy sources, waste management and social integration were considered. Each group identified the key actors for each project, allowing them to approach sustainability from a multilevel perspective. Net Present Value analyses were applied to evaluate economic viability of each project. Photovoltaic power plants and boilers fueled with local wood are the main renewable energy source identified to promote energy sustainability in each project. As result, the combination of the six works creates a powerful tool to demonstrate possible best practices for remote mountain areas.
- Published
- 2022
- Full Text
- View/download PDF
31. REFLECTIONS of the SOUTH AFRICAN MEDIA 1994 - 2019
- Author
-
Sello Hatang, Avashneee Moodley, Ela Gandhi, Jaimal Anand, Anant Singh, Selwyn Bartlett, Alex Mthiyane, Desmond D’sa, Robin Sewlal, Ronesh Dhawraj, Zayn Nabbi, Ashok Ramsarup, Mashilo Boloka, Mapula Sedutla, Uveka Rangappa, Martin Challenor, Kenny Maistry, Zanele Buthelezi, Salma Patel, Zodumo Maphumulo, Kiru Naidoo, Karthy Govender, Sizwe Pamla, Khulekani Magubane, Lumko Mtimde, Bill Siemering, Fred Khumalo, Jeremy Maggs, Mathumo Manaka, Sibusiso Ngalwa, David Hotchkiss, Chris Marnewick, Ryland Fisher, Fakir Hassen, Steve Ahern, Yogas Nair, Peter Glendinning, Jeremy Thompson, Mikhail Peppas, Chief Justice Pius Langa, and Joe Ritchie
- Subjects
business.industry ,Constitution ,media_common.quotation_subject ,Media studies ,Media industry ,Electronic media ,Democracy ,Political science ,Journalism ,China ,business ,Period (music) ,media_common ,Freedom of expression - Abstract
Prior to 1994, the media operated in an environment that can best be described as ‘suppressed’. Diversity of thoughts, views and opinions on media platforms were non-existent as the regime, at the time, ruled with an iron-fist. A variety of print media outlets sought to reflect reality, but it was a steady struggle especially for those with meagre resources, and exacerbated by the constant clampdowns. The state-run broadcaster, if anything, entrenched discriminatory principles and practices. Given our precarious past, the birth of democracy proved to be the perfect panacea for a promising pathway for the media fraternity. Transformation, in more ways than one, permeated the sector. Reflections of the South African Media: 1994-2019 is a compilation by authors who have peculiar insight of and excelled in the different areas of the fast-developing industry in the first 25 years of South Africa’s democracy. And they are no ordinary authors. Every chapter contributed came from women and men who had, through the years, a direct link with ML Sultan Technikon, Technikon Natal, Durban Institute of Technology (DIT) or Durban University of Technology (DUT) * either as a student, lecturer, visiting professor, speaker or associate. Compiling and editing this book has been an incredibly invigorating experience. It was never in doubt whose image will adorn the cover of the book, so it was beautifully uplifting that many authors, not knowing my choice, gave Nelson Mandela due recognition. My brief to the authors was simple: let me have your personal lookback in your own style on the topic that you are most comfortable with. All of them stepped up to the plate, and the vast array of content in the book bares strong testimony. A section titled Journeys in Journalism encapsulates input from alumni of DUT Journalism – they were afforded free reign to trace the territory they traversed. I’m indebted to each and every contributor for generously volunteering their precious time and talent to the book. They were simply magnificent. It has to be said that this publication far exceeded my expectations as it, initially, was a humble idea to celebrate 25 years of the media industry with a handful of contributions. Little did I realise that my desk will be flooded with 40 pieces of excellence and a Foreword penned by the brilliant Jeremy Thompson. My eternal gratitude must also be extended to the small team of assistants for understanding my vision upfront and rallying remarkably throughout. Once you’ve enjoyed the read, I invite you to share Reflections of the South African Media: 1994-2019 with whoever you believe can benefit from its rich and diverse content!
- Published
- 2021
- Full Text
- View/download PDF
32. Radiological characterization of a German pressurized water reactor based on a highly resolved method for activity analysis and dose rate calculation
- Author
-
Nolden, Markus, primary, Scaramus, Agnes, additional, Nabbi, Rahim, additional, Charlier, Frank, additional, and Fischer-Appelt, Klaus, additional
- Published
- 2021
- Full Text
- View/download PDF
33. Impact of Radiation-Induced Microstructures on the Integrity of Spent Nuclear Fuel (SNF) Elements in Long-Term Storage
- Author
-
Yanikömer, Neslihan, primary, Nabbi, Rahim, additional, and Fischer-Appelt, Klaus, additional
- Published
- 2021
- Full Text
- View/download PDF
34. Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study
- Author
-
Abdoli, Asghar, primary, Aalizadeh, Reza, additional, Aminianfar, Hossein, additional, Kianmehr, Zahra, additional, Teimoori, Ali, additional, Azimi, Ebrahim, additional, Emamipour, Nabbi, additional, Eghtedardoost, Marzieh, additional, Siavashi, Vahid, additional, Jamshidi, Hamidreza, additional, Hosseinpour, Mohammadreza, additional, Taqavian, Mohammad, additional, and Jalili, Hasan, additional
- Published
- 2021
- Full Text
- View/download PDF
35. Case Report: Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker [version 1; referees: 2 approved]
- Author
-
Raha Nabbi, Harvey J Woehlck, and Matthias L Riess
- Subjects
Case Report ,Articles ,Anesthetic Mechanisms ,Cardiovascular Medicine in Anesthesia: Basic Science ,Cardiovascular Pharmacology ,Hypertension ,angiotensin receptor blocker ,hypotension ,anesthesia ,vasopressin - Abstract
Due to their beneficial reduction in morbidity and mortality angiotensin receptor blockers (ARBs) have become increasingly popular to treat hypertension. However, similar to angiotensin converting enzyme inhibitors, they can lead to severe hypotension in conjunction with general anesthesia and thus have been recommended to be withheld in the morning of surgery. Here, we present a 51 year old female who developed severe refractory hypotension after induction of general anesthesia, although she had discontinued her medication 24 hours preoperatively as instructed. Therefore, halting ARBs for more than 24 hours before surgery may be necessary. Heightened awareness of this potential interaction and recognizing the need to treat with vasopressin is required when ARB-induced hypotension occurs.
- Published
- 2013
- Full Text
- View/download PDF
36. IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors
- Author
-
Arash Nabbi, Pengbo Beck, Alberto Delaidelli, Derek A Oldridge, Sumedha Sudhaman, Kelsey Zhu, S Y Cindy Yang, David T Mulder, Jeffrey P Bruce, Joseph N Paulson, Pichai Raman, Yuankun Zhu, Martin Silll, Sebastian Brabetz, Sander Lambo, Pascal D Johann, Adam C Resnick, Poul H Sorensen, David Malkin, Marcel Kool, David T W Jones, Stefan M Pfister, Natalie Jäger, and Trevor J Pugh
- Subjects
Cancer Research ,Oncology ,Neurology (clinical) - Abstract
INTRODUCTION: Recent clinical trials of immune checkpoint inhibitors indicated 5-11% response rate in pediatric patients depending on cancer type and expression of target proteins. Currently, a systematic analysis characterizing the immune microenvironment of childhood tumors is lacking. The main objective of this study is to uncover the features of immune microenvironment in pediatric nervous system tumors (pedNST). METHODS: We compiled transcriptomes of 925 tumors from three initiatives, Therapeutically Applicable Research To Generate Effective Treatments (TARGET, n = 149), International Cancer Genome Consortium (ICGC, n = 195) and Children Brain Tumor Tissue Network (CBTN, n = 581). We analyzed the performance of immune deconvolution tools and used publicly available datasets to define immune genesets. We conducted a consensus analysis to assign genes to cell-types and identify immunological groups. RESULTS: We found wide variability in immune infiltration across and within cancer types ranging from cold tumors such as medulloblastoma (2.7% infiltrate) to infiltrated entities such as neurofibroma (22.6%). Consensus clustering revealed four distinct immune clusters. The pediatric inflamed group (10%) included MYCN non-amplified neuroblastoma and ATRT. The myeloid-predominant group (30%) showed decreased infiltration of lymphoid cells but enrichment of myeloid cell genesets. The pediatric-cold group (42%) harbored no enrichment of immune genesets and included 72% of ependymomas and 65% of medulloblastomas. The immune excluded group (18%) showed depletion of immune cell-types and included sonic-hedgehog medulloblastoma. 71% of pedNST belonged to the lymphocyte depleted or immunologically quiet clusters, indicating the cold immune microenvironment in pedNST compared to adult cancers. CONCLUSION: We report characteristics of the immune microenvironment in pedNST. We found an overall cold microenvironment with low lymphocyte infiltration in this population compared to common adult cancers. We identified ~10% of tumors harboring a relatively inflamed microenvironment. Our data uncover characteristics of immune infiltration in pediatric tumors with potential implications to guide therapy.
- Published
- 2022
- Full Text
- View/download PDF
37. Vermittlung fundamentaler Ideen der Informatik durch eine kollaborative Multitouch-Anwendung.
- Author
-
Negah Nabbi, Philipp Brauner, and Thiemo Leonhardt
- Published
- 2010
38. The Jülich high-brilliance neutron source project
- Author
-
Rücker, U., Cronert, T., Voigt, J., Dabruck, J. P., Doege, P. -E., Ulrich, J., Nabbi, R., Beßler, Y., Butzek, M., Büscher, M., Lange, C., Klaus, M., Gutberlet, T., and Brückel, T.
- Published
- 2016
- Full Text
- View/download PDF
39. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
- Author
-
Anirban Das, Sumedha Sudhaman, Daniel Morgenstern, Ailish Coblentz, Jiil Chung, Simone C. Stone, Noor Alsafwani, Zhihui Amy Liu, Ola Abu Al Karsaneh, Shirin Soleimani, Hagay Ladany, David Chen, Matthew Zatzman, Vanja Cabric, Liana Nobre, Vanessa Bianchi, Melissa Edwards, Lauren C, Sambira Nahum, Ayse B. Ercan, Arash Nabbi, Shlomi Constantini, Rina Dvir, Michal Yalon-Oren, Gadi Abebe Campino, Shani Caspi, Valerie Larouche, Alyssa Reddy, Michael Osborn, Gary Mason, Scott Lindhorst, Annika Bronsema, Vanan Magimairajan, Enrico Opocher, Rebecca Loret De Mola, Magnus Sabel, Charlotta Frojd, David Sumerauer, David Samuel, Kristina Cole, Stefano Chiaravalli, Maura Massimino, Patrick Tomboc, David S. Ziegler, Ben George, An Van Damme, Nobuko Hijiya, David Gass, Rose B. McGee, Oz Mordechai, Daniel C. Bowers, Theodore W. Laetsch, Alexander Lossos, Deborah T. Blumenthal, Tomasz Sarosiek, Lee Yi Yen, Jeffrey Knipstein, Anne Bendel, Lindsey M. Hoffman, Sandra Luna-Fineman, Stefanie Zimmermann, Isabelle Scheers, Kim E. Nichols, Michal Zapotocky, Jordan R. Hansford, John M. Maris, Peter Dirks, Michael D. Taylor, Abhaya V. Kulkarni, Manohar Shroff, Derek S. Tsang, Anita Villani, Wei Xu, Melyssa Aronson, Carol Durno, Adam Shlien, David Malkin, Gad Getz, Yosef E. Maruvka, Pamela S. Ohashi, Cynthia Hawkins, Trevor J. Pugh, Eric Bouffet, Uri Tabori, UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, and UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique
- Subjects
Adult ,DNA Replication ,Male ,Adolescent ,DNA Repair ,Pediatric Cancer ,Immunology ,Cancer immunotherapy ,Medical and Health Sciences ,General Biochemistry, Genetics and Molecular Biology ,B7-H1 Antigen ,Article ,Paediatric cancer ,Tumour biomarkers ,Young Adult ,Rare Diseases ,Neoplasms ,Genetics ,Biomarkers, Tumor ,Tumor Microenvironment ,2.1 Biological and endogenous factors ,Humans ,Prospective Studies ,Aetiology ,Child ,Immune Checkpoint Inhibitors ,Cancer genetics ,Germ-Line Mutation ,Cancer ,Retrospective Studies ,Pediatric ,Tumor ,Neurosciences ,General Medicine ,Survival Analysis ,CNS cancer ,Female ,Biomarkers - Abstract
Cancers arising from germline DNA mismatch repair deficiency or polymerase proofreading deficiency (MMRD and PPD) in children harbour the highest mutational and microsatellite insertion–deletion (MS-indel) burden in humans. MMRD and PPD cancers are commonly lethal due to the inherent resistance to chemo-irradiation. Although immune checkpoint inhibitors (ICIs) have failed to benefit children in previous studies, we hypothesized that hypermutation caused by MMRD and PPD will improve outcomes following ICI treatment in these patients. Using an international consortium registry study, we report on the ICI treatment of 45 progressive or recurrent tumors from 38 patients. Durable objective responses were observed in most patients, culminating in a 3 year survival of 41.4%. High mutation burden predicted response for ultra-hypermutant cancers (>100 mutations per Mb) enriched for combined MMRD + PPD, while MS-indels predicted response in MMRD tumors with lower mutation burden (10–100 mutations per Mb). Furthermore, both mechanisms were associated with increased immune infiltration even in ‘immunologically cold’ tumors such as gliomas, contributing to the favorable response. Pseudo-progression (flare) was common and was associated with immune activation in the tumor microenvironment and systemically. Furthermore, patients with flare who continued ICI treatment achieved durable responses. This study demonstrates improved survival for patients with tumors not previously known to respond to ICI treatment, including central nervous system and synchronous cancers, and identifies the dual roles of mutation burden and MS-indels in predicting sustained response to immunotherapy., Hypermutation and microsatellite burden determine responses and long-term survival following PD-1 blockade in children and young adults with refractory cancers resulting from germline DNA replication repair deficiency.
- Published
- 2021
40. Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study
- Author
-
Abdoli, Asghar, primary, Aalizadeh, Reza, additional, Aminianfar, Hossein, additional, Kianmehr, Zahra, additional, Azimi, Ebrahim, additional, Emamipour, Nabbi, additional, Jamshidi, Hamidreza, additional, Hosseinpour, Mohammadreza, additional, Taqavian, Mohammad, additional, and Jalili, Hasan, additional
- Published
- 2021
- Full Text
- View/download PDF
41. IMMU-14. COMPUTATIONAL DECONVOLUTION OF TUMOR-INFILTRATING IMMUNE COMPONENTS IN PEDIATRIC NERVOUS SYSTEM TUMORS
- Author
-
Beck, Pengbo, primary, Nabbi, Arash, additional, Sill, Martin, additional, Sudhaman, Sumedha, additional, Kool, Marcel, additional, Resnick, Adam C, additional, Jones, David T W, additional, Pfister, Stefan M, additional, Pugh, Trevor J, additional, and Jäger, Natalie, additional
- Published
- 2021
- Full Text
- View/download PDF
42. Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker [v1; ref status: indexed, http://f1000r.es/p1]
- Author
-
Raha Nabbi, Harvey J Woehlck, and Matthias L Riess
- Subjects
Anesthetic Mechanisms ,Cardiovascular Medicine in Anesthesia: Basic Science ,Cardiovascular Pharmacology ,Hypertension ,Medicine ,Science - Abstract
Due to their beneficial reduction in morbidity and mortality angiotensin receptor blockers (ARBs) have become increasingly popular to treat hypertension. However, similar to angiotensin converting enzyme inhibitors, they can lead to severe hypotension in conjunction with general anesthesia and thus have been recommended to be withheld in the morning of surgery. Here, we present a 51 year old female who developed severe refractory hypotension after induction of general anesthesia, although she had discontinued her medication 24 hours preoperatively as instructed. Therefore, halting ARBs for more than 24 hours before surgery may be necessary. Heightened awareness of this potential interaction and recognizing the need to treat with vasopressin is required when ARB-induced hypotension occurs.
- Published
- 2013
- Full Text
- View/download PDF
43. Atezolizumab and Granzyme B as Immunotoxin Against PD-L1 Antigen; An Insilico Study
- Author
-
Fateme Sefid, Zahra Payandeh, Behzad Baradaran, Mohsen Nabbi, Maryam Islami, Maryam Darvish, and Seyed Mehdi Kalantar
- Abstract
Background Programmed death-ligand 1 (PD-L1), also called B7 homolog 1 (B7-H1), is a human protein playing an important biomarker role in highly proliferation cells (like cancer cells) which is encoded by the CD274 gene. The interaction between PD-1 and PD-L1 inhibits T cell growth and cytokine secretion. Therefore, PD-L1 negatively regulates immune responses and permits tumor cells to evade immune surveillance. Thus, PD-L1 seems to be a suitable target for designing the immune-therapeutics. Results The predicted structure of this protein indicated that the chains were linked by (Gly4Ser)3 linker. In that line, using different simulation software, the structure of Granzyme B (GrB), a serine protease exists in cytotoxic lymphocytes granules as an apoptosis mediator, was attached to its specific antibody structure (Atezolizumab) via an adaptor sequence. Evaluation of accuracy, energy minimization and characterization of biological properties of the final processed structure were done. Our computational outcomes showed that the method of employed structure prediction has been successfully managed to design the immunotoxin structure. Conclusion It is necessary to mention that the precise and accurate design of the immune-therapeutic agents against cancer cells, can be confirmed by employed in-silico approach. So, using this method, we have designed a capable immunotoxin targeting the PD-L1 in an accurate orientation and cause the cancer cell destruction by its toxin domain.
- Published
- 2020
- Full Text
- View/download PDF
44. The Optimum Types and Characteristics of Drilling Fluids Used During Drilling in The Egyption Westren Desert
- Author
-
M. S. Abd El Nabbi, M. S. Farahat, and A. A. Elgibaly
- Subjects
Lost circulation ,Petroleum engineering ,Drilling fluid ,Environmental science ,Drilling ,Well control - Abstract
In this study, the factors that affect the selection of the types and characteristics of drilling fluids that were used while drilling nine wells in the Egyptian Western Desert were investigated. This study proves that the selection of drilling fluid type is not only based on the applications of drilling fluids, cost of drilling fluid or previous experience but also on other factors combined together such as geology of the area, potential problems for each section, make up base fluids availability, waste management techniques, environmental regulations, rig and drilling equipments and drilling data. In this study also, the evaluation of the designed characteristics of the selected types of drilling fluids was made to achieve the required functions such as good hole cleaning, well control, hole stability and to reduce lost circulation problem.
- Published
- 2018
- Full Text
- View/download PDF
45. Parametric study and design improvements for the target of NOVA ERA
- Author
-
Johannes Baggemann, Michael Butzek, Ulrich Rücker, Rahim Nabbi, Thomas Gutberlet, Paul Zakalek, Sarah Böhm, Paul-Emmanuel Doege, Jörg Wolters, Eric Mauerhofer, G. Natour, Tobias Cronert, Y. Beßler, and Thomas Brückel
- Subjects
Physics ,Nuclear and High Energy Physics ,Nuclear Energy and Engineering ,010308 nuclear & particles physics ,0103 physical sciences ,Nova (laser) ,010403 inorganic & nuclear chemistry ,01 natural sciences ,Industrial engineering ,0104 chemical sciences ,Parametric statistics - Published
- 2018
- Full Text
- View/download PDF
46. Demethylating Agents as Epigenetic Anticancer Therapeutics
- Author
-
Riabowol, Karl, Nabbi, Arash, and Satpathy, Shankha
- Published
- 2013
47. Role of oxidative folding in the dimeric assembly of TMEM16A(a)/anoctamin-1: 350
- Author
-
Schmalzing, Gunther, Detro-Dassen, Silvia, Nabbi, Danje, Braam, Ursula, Klapperstueck, Manuela, and Markwardt, Fritz
- Published
- 2012
48. Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue
- Author
-
Nabbi, R., Riess, M. L., and Woehlck, H. J.
- Published
- 2012
- Full Text
- View/download PDF
49. The Genomic Landscape of Pediatric Renal Cell Carcinomas
- Author
-
Beck, Pengbo, primary, Selle, Barbara, additional, Madenach, Lukas, additional, Jones, David T.W., additional, Vokuhl, Christian, additional, Gopisetty, Apurva, additional, Nabbi, Arash, additional, Brecht, Ines B., additional, Ebinger, Martin, additional, Wegert, Jenny, additional, Graf, Norbert, additional, Gessler, Manfred, additional, Pfister, Stefan M., additional, and Jäger, Natalie, additional
- Published
- 2021
- Full Text
- View/download PDF
50. Atezolizumab and Granzyme B as Immunotoxin Against PD-L1 Antigen; An Insilico Study
- Author
-
Sefid, Fateme, primary, Payandeh, Zahra, additional, Baradaran, Behzad, additional, Nabbi, Mohsen, additional, Islami, Maryam, additional, Darvish, Maryam, additional, and Kalantar, Seyed Mehdi, additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.